Effect of Pregnancy on Cytochrome P450 3a and P-Glycoprotein Expression and Activity in the Mouse: Mechanisms, Tissue Specificity, and Time Course
- 1 September 2008
- journal article
- Published by Elsevier in Molecular Pharmacology
- Vol. 74 (3) , 714-723
Abstract
The plasma concentrations of orally administered anti-human immunodeficiency virus protease inhibitors are significantly reduced during human and mouse pregnancy. We have shown that in the mouse, at gestational day 19, this reduction is due to increased hepatic cytochrome P450 3a (Cyp3a) protein expression and activity. In the current study, we investigated the mechanisms by which Cyp3a activity is increased by pregnancy and the time course of change in expression of Cyp3a and P-glycoprotein (P-gp) in various tissues. We found that hepatic transcripts of Cyp3a16, Cyp3a41, and Cyp3a44 were significantly increased during pregnancy, whereas those of Cyp3a11 and Cyp3a25 were significantly decreased. This resulted in a net increase in Cyp3a protein expression and activity in the liver during pregnancy. The increase in Cyp3a41 and Cyp3a44 transcripts was positively correlated (p < 0.05) with hepatocyte nuclear factor 6 and estrogen receptor-α transcripts. The pregnancy-related factors that transcriptionally activated mouse Cyp3a isoforms also activated the human CYP3A4 promoter in pregnant CYP3A4-promoter-luciferase transgenic (CYP3A4-tg) mice. In contrast, intestinal Cyp3a protein expression was not significantly affected by pregnancy. No change in P-gp protein expression was observed in the liver or kidney during pregnancy, although a significant decrease was observed in the placenta. Because hepatic CYP3A activity also seems to be induced during human pregnancy, the mouse (including CYP3A4-tg mouse) seems to be an excellent animal model to determine the molecular mechanisms for such an induction.Keywords
This publication has 37 references indexed in Scilit:
- Pharmacokinetics and Safety of Indinavir in Human Immunodeficiency Virus-Infected Pregnant WomenAntimicrobial Agents and Chemotherapy, 2007
- Expression of the breast cancer resistance protein (Bcrp1/Abcg2) in tissues from pregnant mice: effects of pregnancy and correlations with nuclear receptorsAmerican Journal of Physiology-Endocrinology and Metabolism, 2006
- Growth Hormone Determines Sexual Dimorphism of Hepatic Cytochrome P450 3A4 Expression in Transgenic MiceThe Journal of Pharmacology and Experimental Therapeutics, 2006
- Changes in Pharmacokinetics of Anti-HIV Protease Inhibitors during Pregnancy: The Role of CYP3A and P-glycoproteinThe Journal of Pharmacology and Experimental Therapeutics, 2006
- Modified expression of cytochrome P450 mRNAs by growth hormone in mouse liverToxicology, 2006
- Temporal changes in drug metabolism (CYP1A2, CYP2D6 and CYP3A Activity) during pregnancyAmerican Journal of Obstetrics and Gynecology, 2005
- Nelfinavir Plasma Concentrations Are Low during PregnancyClinical Infectious Diseases, 2004
- A TRANSGENIC MOUSE MODEL WITH A LUCIFERASE REPORTER FOR STUDYING IN VIVO TRANSCRIPTIONAL REGULATION OF THE HUMAN CYP3A4 GENEDrug Metabolism and Disposition, 2003
- Genomic characterization and regulation of CYP3a13: role of xenobiotics and nuclear receptorsThe FASEB Journal, 2003
- An argument for routine therapeutic drug monitoring of HIV-1 protease inhibitors during pregnancyAIDS, 2001